Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.31 |
| ▸ | CA12 | O43570 | 2/20 | 0.30 |
| ▸ | CA9 | Q16790 | 2/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27285185 | 1.00 | MAPT (0.33) | MAPTCYP19A1CA12CA9 | |
| SCHEMBL27285257 | 1.00 | MAPT (0.33) | MAPTCYP19A1CA12CA9 | |
| SCHEMBL27285208 | 1.00 | MAPT (0.33) | MAPTCYP19A1CA12CA9 | |
| SCHEMBL31088243 | 0.82 | CYP19A1 (0.33) | MAPTCYP19A1CA12CA9 | |
| SCHEMBL25162188 | 0.80 | MAPT (0.33) | MAPT | |
| SCHEMBL22806547 | 0.80 | MAPT (0.33) | MAPT | |
| SCHEMBL27285261 | 0.80 | MAPT (0.33) | MAPT | |
| SCHEMBL25162281 | 0.80 | MAPT (0.33) | MAPT | |
| SCHEMBL27285253 | 0.80 | MAPT (0.33) | MAPT | |
| SCHEMBL27285291 | 0.80 | MAPT (0.32) | MAPTCYP19A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240207434-A1 | METHODS FOR PREPARING CYCLOOCTENES ANDCONJUGATES THEREOF | TAGWORKS PHARMACEUTICALS B.V. (NL) | 2024-06-27 | — | — | US | disclosed |
| US-20240207434-A1 | METHODS FOR PREPARING CYCLOOCTENES ANDCONJUGATES THEREOF | TAGWORKS PHARMACEUTICALS B.V. (NL) | 2024-06-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240207434-A1 | METHODS FOR PREPARING CYCLOOCTENES ANDCONJUGATES THEREOF | PAICS, PTMS, MSN | MAPT 3732/4885CYP19A1 81/4885CA12 550/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.